AAAAAA

   
Results: 1-9 |
Results: 9
Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: Transition state inhibitors
Authors: Bachand, B Tarazi, M St-Denis, Y Edmunds, JJ Winocour, PD Leblond, L Siddiqui, MA
Citation: B. Bachand et al., Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: Transition state inhibitors, BIOORG MED, 11(3), 2001, pp. 287-290
Novel bicyclic lactam inhibitors of thrombin: Potency and selectivity optimization through P1 residues
Authors: Levesque, S St-Denis, Y Bachand, B Preveille, P Leblond, L Winocour, PD Edmunds, JJ Rubin, JR Siddiqui, MA
Citation: S. Levesque et al., Novel bicyclic lactam inhibitors of thrombin: Potency and selectivity optimization through P1 residues, BIOORG MED, 11(24), 2001, pp. 3161-3164
An efficient synthesis of 2-(3-(4-amidinophenylcarbamoyl)naphthalen-2-yl)5-((2,2-methylpropyl)carbamoyl)benzoic acid: a factor VIIa inhibitor discovered by the Ono Pharmaceutical Company
Authors: Kohrt, JT Filipski, KJ Rapundalo, ST Cody, WL Edmunds, JJ
Citation: Jt. Kohrt et al., An efficient synthesis of 2-(3-(4-amidinophenylcarbamoyl)naphthalen-2-yl)5-((2,2-methylpropyl)carbamoyl)benzoic acid: a factor VIIa inhibitor discovered by the Ono Pharmaceutical Company, TETRAHEDR L, 41(32), 2000, pp. 6041-6044
Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors
Authors: Dudley, DA Bunker, AM Chi, LG Cody, WL Holland, DR Ignasiak, DP Janiczek-Dolphin, N McClanahan, TB Mertz, TE Narasimhan, LS Rapundalo, ST Trautschold, JA Van Huis, CA Edmunds, JJ
Citation: Da. Dudley et al., Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors, J MED CHEM, 43(22), 2000, pp. 4063-4070
Potent and selective bicyclic lactam inhibitors of thrombin: Part 3: P1 ' modifications
Authors: Plummer, JS Berryman, KA Cai, CM Cody, WL DiMaio, J Doherty, AM Eaton, S Edmunds, JJ Holland, DR Lafleur, D Levesque, S Narasimhan, LS Rubin, JR Rapundalo, T Siddiqui, MA Susser, A St-Denis, Y Winocour, P
Citation: Js. Plummer et al., Potent and selective bicyclic lactam inhibitors of thrombin: Part 3: P1 ' modifications, BIOORG MED, 9(6), 1999, pp. 835-840
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 1
Authors: Cody, WL Cai, CM Doherty, AM Edmunds, JJ He, JX Narasimhan, LS Plummer, JS Rapundalo, ST Rubin, JR Van Huis, CA St-Denis, Y Winocour, PD Siddiqui, MA
Citation: Wl. Cody et al., The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 1, BIOORG MED, 9(17), 1999, pp. 2497-2502
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 2
Authors: Cody, WL Augelli-Szafran, CE Berryman, KA Cai, CM Doherty, AM Edmunds, JJ He, JX Narasimhan, LS Penvose-Yi, J Plummer, JS Rapundalo, ST Rubin, JR Van Huis, CA Leblond, L Winocour, PD Siddiqui, MA
Citation: Wl. Cody et al., The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 2, BIOORG MED, 9(17), 1999, pp. 2503-2508
Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications
Authors: Plummer, JS Berryman, KA Cai, C Cody, WL DiMaio, J Doherty, AM Edmunds, JJ He, JX Holland, DR Levesque, S Kent, DR Narasimhan, LS Rubin, JR Rapundalo, ST Siddiqui, MA Susser, AJ St-Denis, Y Winocour, PD
Citation: Js. Plummer et al., Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications, BIOORG MED, 8(23), 1998, pp. 3409-3414
Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications
Authors: St-Denis, Y Augelli-Szafran, CE Bachand, B Berryman, KA DiMaio, J Doherty, AM Edmunds, JJ Leblond, L Levesque, S Narasimhan, LS Penvose-Yi, JR Rubin, JR Tarazi, M Winocour, PD Siddiqui, MA
Citation: Y. St-denis et al., Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications, BIOORG MED, 8(22), 1998, pp. 3193-3198
Risultati: 1-9 |